Holen Sie sich die Stockscreener-App
115.68
0.06%
0.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$115.55
Offen:
$115.18
24-Stunden-Volumen:
621.02K
Relative Volume:
0.29
Marktkapitalisierung:
$32.69B
Einnahmen:
$7.07B
Nettoeinkommen (Verlust:
$1.29B
KGV:
25.51
EPS:
4.5355
Netto-Cashflow:
$993.00M
1W Leistung:
-4.41%
1M Leistung:
+4.88%
6M Leistung:
-21.13%
1J Leistung:
+8.79%
1-Tages-Spanne:
$115.18
$117.33
1-Wochen-Bereich:
$111.98
$124.89
52-Wochen-Spanne:
$104.10
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
115.67 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
466.71 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.53 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
575.50 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
302.37 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent Technologies, Inc. $A Stock Holdings Decreased by Pictet Asset Management Holding SA - MarketBeat
At US$116, Is It Time To Put Agilent Technologies, Inc. (NYSE:A) On Your Watch List? - Yahoo Finance
Teacher Retirement System of Texas Sells 66,755 Shares of Agilent Technologies, Inc. $A - MarketBeat
Here's what to expect from Agilent Technologies’ next earnings report - MSN
Agilent Q1 earnings miss estimates, revenues up Y/Y, shares fall - MSN
Agilent Technologies declares $0.255 dividend - MSN
Agilent opens new biopharma centre in Hyd - MSN
Agilent Technologies Inc. stock (US00846U1016): Why its life sciences leadership matters more now fo - AD HOC NEWS
Agilent Technologies Inc. stock (US00846U1016): Why Google Discover changes matter more now - AD HOC NEWS
Is Agilent Technologies stock underperforming the S&P 500? - MSN
Agilent Technologies, Inc. $A is Impax Asset Management Group plc's 6th Largest Position - MarketBeat
Agilent doubling headcount in India - The Economic Times
Here's What to Expect From Agilent Technologies’ Next Earnings Report - Barchart.com
Agilent Technologies Inc (NYSE:A): A Quality Investing Candidate with Strong Profitability and Cash Flow - ChartMill
Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues? - simplywall.st
Agilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Earnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSN
Agilent to acquire Biocare Medical for $950M, expanding pathology portfolio - MSN
Universal Beteiligungs und Servicegesellschaft mbH Sells 54,276 Shares of Agilent Technologies, Inc. $A - MarketBeat
Boston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat
Is Agilent Technologies a Better Buy Than Danaher? - Trefis
Agilent appoints Rodney Gonsalves as interim CFO following McMahon’s departure - MSN
Global Cloud ELN Service Market | USA, China, India Lead | Thermo Fisher Scientific, Agilent Technologies, Dassault Systèmes Drive Digital Lab Transformation - The AI Journal
TRADE NEWS: Agilent Technologies Introduces HaloPlex Next-Generation Sequencing Panels Targeting Can - Yahoo
Agilent’s Expanding Role in Advanced Therapeutics - Contract Pharma
Agilent Technologies (A) Launches Key Cancer Diagnostic Tool - GuruFocus
Agilent Technologies, Inc. $A Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Agilent Technologies Inc. stock (US00846U1016): Is life sciences strength enough to drive steady gai - AD HOC NEWS
Axion Biosystems and Agilent Technologies Res - Moomoo
Axion Biosystems And Agilent Technologies Resolve Litigation - TradingView
Agilent bets on pathology innovation with Biocare acquisition - MSN
Axion BioSystems and Agilent Technologies Resolve Litigation - Business Wire
Mirae Asset Global Investments Co. Ltd. Grows Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies Inc stock (US00846U1016): Why Google Discover changes matter more now - AD HOC NEWS
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 31.85% Potential Upside for Investors - DirectorsTalk Interviews
Chromatograph (Labor): Precision Tools Drive Agilent's Lab Market Edge - AD HOC NEWS
Agilent Cancer Research Push Spurs Collaboration Focus And Investor Reassessment - Yahoo Finance
Chromatograph (Labor): Advances in Tech Boost Agilent's Lab Market Edge - AD HOC NEWS
11,390 Shares in Agilent Technologies, Inc. $A Acquired by Lecap Asset Management Ltd. - MarketBeat
KBC Group NV Has $11.17 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Agilent Stock Performance & Valuation Analysis 2026 | Business ReviewNews and Statistics - IndexBox
Is Agilent’s Oncology Push and Oxford Nanopore Tie-Up Quietly Reframing Its Investment Narrative (A)? - Sahm
Agilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies, Inc. $A Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Q4 2025 Earnings Call Transcript - MSN
Agilent Technologies Inc stock (US00846U1016): Why its life sciences leadership matters more now for - AD HOC NEWS
Agilent (A) Showcases Innovations at AACR 2026 Annual Meeting - GuruFocus
Agilent Ekes Higher Ahead of Cancer Research Conference - Baystreet.ca
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.42%
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):